| Appearance | White to Beige Powder |
| Purity(HPLC) | ≥ 97.5 % |
| Water Content | 0.0 – 2.0 mol |
| Optical Rotation (C= 1, CDCl3) | -95.0 – -85.0 ° |
Efinaconazole
(αR,βR)-, α-(2,4-Difluorophenyl)-β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; (2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
| Purity / Analysis Method | ≥ 97.5 % (HPLC) |
| Molecular Formula / Molecular Weight | C18H22F2N4O = 348.39 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 164650-44-6 |
| Unit | Price |
| 100 mg | 7000 |
| 250 mg | 9500 |
| 1 g | 14900 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
